Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Wall Street Analysts Predict a 25.24% Upside in Clearway Energy (CWEN): Here's  What You Should Know
Wall Street Analysts Predict a 25.24% Upside in Clearway Energy (CWEN): Here's What You Should Know

Clearway Energy (CWEN) closed the last trading session at $28.61, gaining 2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Can Pfizer (PFE) Climb 25.14% to Reach the Level Wall Street Analysts Expect?
Can Pfizer (PFE) Climb 25.14% to Reach the Level Wall Street Analysts Expect?

Pfizer (PFE) closed the last trading session at $22.79, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Does Novo Nordisk (NVO) Have the Potential to Rally 51.24% as Wall Street Analysts Expect?
Does Novo Nordisk (NVO) Have the Potential to Rally 51.24% as Wall Street Analysts Expect?

Novo Nordisk (NVO) closed the last trading session at $67.55, gaining 3.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Does Adaptive Biotechnologies (ADPT) Have the Potential to Rally 26.45% as Wall Street Analysts Expect?
Does Adaptive Biotechnologies (ADPT) Have the Potential to Rally 26.45% as Wall Street Analysts Expect?

Shares of Adaptive Biotechnologies (ADPT) have gained 5.1% over the past four weeks to close the last trading session at $8.81, but there could still be a solid upside left in the stock if

Does BioCryst (BCRX) Have the Potential to Rally 61.21% as Wall Street Analysts Expect?
Does BioCryst (BCRX) Have the Potential to Rally 61.21% as Wall Street Analysts Expect?

BioCryst Pharmaceuticals (BCRX) closed the last trading session at $10.08, gaining 48.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates
IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates

Ironwood Pharmaceuticals IRWD reported an adjusted loss of 14 cents per share for the first quarter of 2025, which was wider than the Zacks Consensus Estimate of a loss of 5 cents. The company had

Manulife Q1 Earnings Miss Expectations, NBV Sales Rise Y/Y
Manulife Q1 Earnings Miss Expectations, NBV Sales Rise Y/Y

Manulife Financial Corporation MFC delivered first-quarter 2025 core earnings of 69 cents per share, which missed the Zacks Consensus Estimate by 1.4%. The bottom line decreased 1.4% year over year

Universal Technical's Q2 Earnings Beat Estimates, FY25 View Up
Universal Technical's Q2 Earnings Beat Estimates, FY25 View Up

Universal Technical Institute, Inc.’s UTI stock gained 11.4% in yesterday’s after-hours trading session as it reported impressive second-quarter fiscal 2025 results. Both earnings and revenues

APEI to Report Q1 Earnings: What's in Store for the Stock?
APEI to Report Q1 Earnings: What's in Store for the Stock?

American Public Education, Inc. APEI is slated to report first-quarter 2025 results on May 12, after market close.In the last reported quarter, the company’s earnings per share (EPS) and revenues

Here's Why Twilio (TWLO) is a Strong Momentum Stock
Here's Why Twilio (TWLO) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Why Universal Health Services (UHS) is a Top Momentum Stock for the Long-Term
Why Universal Health Services (UHS) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why Halozyme Therapeutics (HALO) is a Top Momentum Stock for the Long-Term
Why Halozyme Therapeutics (HALO) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Allison Transmission (ALSN) is a Strong Momentum Stock
Here's Why Allison Transmission (ALSN) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Kroger (KR) is a Strong Momentum Stock
Here's Why Kroger (KR) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Scoop Up These 4 GARP Stocks to Receive Handsome Returns
Scoop Up These 4 GARP Stocks to Receive Handsome Returns

If you are looking for a profitable portfolio of stocks offering the best of value and growth investing, try the growth at a reasonable price or GARP strategy.The strategy helps investors gain

Here's Why Aecom Technology (ACM) is a Strong Growth Stock
Here's Why Aecom Technology (ACM) is a Strong Growth Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why MasTec (MTZ) is a Top Growth Stock for the Long-Term
Why MasTec (MTZ) is a Top Growth Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Palantir Technologies Inc. (PLTR) is a Top-Ranked Growth Stock: Should You Buy?
Palantir Technologies Inc. (PLTR) is a Top-Ranked Growth Stock: Should You Buy?

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

ScanSource (SCSC) Beats Q3 Earnings Estimates
ScanSource (SCSC) Beats Q3 Earnings Estimates

ScanSource (SCSC) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.77 per share. This compares to earnings of $0.69 per share a year ago. These figures